Articles BRAF Signaling Inhibition in Glioblastoma:… 4 February 2022 by palerma 0 comments p53 Antibodies as a Diagnostic… 4 February 2022 by palerma 0 comments Clinical, Radiometabolic and Immunologic Effects… 4 February 2022 by palerma 0 comments Anthracyclines Strike Back: Rediscovering Non-Pegylated… 4 February 2022 by palerma 0 comments Tumor Type Agnostic Therapy Carrying… 4 February 2022 by palerma 0 comments Role of the IGF-1 Axis… 4 February 2022 by palerma 0 comments Endocrine-Based Treatments in Clinically-Relevant Subgroups… 4 February 2022 by palerma 0 comments Targeting Aberrant FGFR Signaling to… 4 February 2022 by palerma 0 comments Early Changes of the Standardized… 3 February 2022 by palerma 0 comments Abemaciclib: current role for treating… 3 February 2022 by palerma 0 comments Immune system and angiogenesis‑related potential… 10 November 2020 by palerma 0 comments Seroconversion in patients with cancer… 10 November 2020 by palerma 0 comments